Diclofenac may serve as useful adjunct to anti-VEGF in DME treatment
Intravitreal injection of diclofenac as an adjunct or alternative to other treatments such as anti-VEGF drugs might enhance the functional outcomes in eyes with naïve diabetic macular oedema (DME), according to a study presented at the 13th EURETINA Congress.
“The efficacy of intravitreal diclofenac (IVD) is probably due to its effect on retinal perfusion rather than on leakage reduction. Diclofenac may enhance both rod- and cone-mediated inner retinal responses,” said Masoud Soheilian MD.
The purpose of the study was set out to compare single injection of IVD (VD) with intravitreal bevacizumab (IVB) in the treatment of eyes with naïve diabetic macular oedema (DME).
In this randomised clinical trial, 57 eyes of 57 patients were randomly assigned to IVD group (30 eyes) who received a single intravitreal injection of diclofenac and IVB group (27 eyes) who received a single intravitreal injection of bevacizumab. Change in best-corrected visual acuity in logMAR at week 12 was the primary outcome measure. Secondary outcomes included changes in central macular thickness, macular leakage and potential injection-related complications.
Tags: intraocular pressure
Latest Articles
Addressing Postoperative Visual Complications
Managing aberrations after laser refractive surgery requires a multi-layered approach.
3D Printing Helps Transform Ukrainian Eye Care
The country’s ophthalmologists offer valuable experience in treating ocular trauma and prosthesis design.
Winning Essay Says ‘Collective Desire’ Must Drive DEI Implementation
Emerging Microbial Trends That Could Affect Your Practices
A triptych of challenges paints a concerning picture for ophthalmologists across the globe.
Improving Outcomes with Laser-Assisted Surgery
Femtosecond laser offers a multifunctional tool for improving the safety and efficacy of cataract and refractive lens exchange procedures.
Could the Corneal Transplant Pool Increase?
Modifying or discarding major contraindications for keratoplasty could mean more patients have their sight restored.
Matching Premium IOLs to Visual Lifestyles
From monofocal to full-range solutions, each practice needs comprehensive understanding.
Going Dutch on Acanthamoeba Keratitis
A world-first trial suggests a new medication could beat the disease.
Avoiding Intracorneal Ring Segment Complications
Femtosecond lasers are helping improve refractive results with fewer problems.